Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Moleculin Biotech Inc | 3 | 27 | 1 | 2 | €0.41 | €18.42 | 4393.659% |
| Novan Inc | 0 | 24 | 0 | 2 | €0.001 | - | - |
| Evoke Pharma Inc. | 0 | 22 | 0 | 0 | €0.41 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| Trevena Inc. | 1 | 14 | 0 | 3 | €0.33 | €8.37 | 2446.849% |
| Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
| Organovo Holdings Inc. | 0 | 5 | 0 | 0 | €0.88 | - | - |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 1 | €2.26 | €7.00 | 209.735% |
| Fibrogen Inc. | 1 | 4 | 0 | 1 | €0.95 | €0.000 | -100.000% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.87 | €8.82 | 914.458% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.50 | - | - |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €6.15 | €7.00 | 13.821% |
| Sangamo Therapeutics Inc. | 11 | 13 | 0 | 1 | €0.49 | €2.79 | 474.168% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.42 | - | - |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.62 | - | - |
| Immuron | 0 | 1 | 0 | 1 | €2.16 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.92 | - | - |
| Grifols S.A. ADR | 0 | 1 | 0 | 0 | €5.90 | - | - |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €3.84 | - | - |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.62 | €3.00 | 380.769% |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €9.80 | €22.00 | 124.490% |
| Cytomx Therapeutics Inc | 2 | 2 | 2 | 2 | €4.21 | €50.00 | 1087.648% |
| Agenus Inc. | 2 | 2 | 0 | 0 | €0.41 | €7.30 | 1664.911% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.02 | €3.00 | 48.588% |